Healthcare -
Biotechnology - NASDAQ - US
$ 3.32
0.61 %
$ 86.3 M
Market Cap
-0.3
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Senti Biosciences, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 61 M |
| Operating Income | -61 M |
| Other Expenses | -8.25 M |
| Net Income | -52.8 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 2.6 | 4.3 | 2.3 | 0.4 | 85 K |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 5.2 | 3.9 | 3.0 | 16.0 | 14.5 |
| Gross Profit | 0 | (2.7) | 0.4 | (0.7) | (15.6) | (14.4) |
| OPERATING INCOME | ||||||
| Operating Expenses | 61.0 | 95.3 | 74.9 | 42.7 | 25.1 | 7.4 |
| Selling, General and Administrative Expenses | 26.4 | 34.9 | 40.8 | 21.2 | 9.3 | 7.3 |
| Research and Development Expenses | 34.4 | 32.1 | 34.1 | 22.0 | 16.0 | 14.5 |
| Operating Income | (61.0) | (92.7) | (70.6) | (40.4) | (24.7) | (21.8) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 8.2 | 9.3 | 12.4 | (14.9) | 4.8 | 0.6 |
| Pre-Tax Income | (52.8) | (83.4) | (58.2) | (55.3) | (19.9) | (21.2) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | (12.4) | 11 K | 0.1 | 0 |
| Net Income | (52.8) | (92.9) | (58.2) | (55.3) | (19.9) | (21.2) |
| EPS | 11.5 | 20.9 | 13.2 | 12.7 | 4.55 | 15.6 |